Isracann Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan '26 Jan 13, 2026	May '22 May 31, 2022	May '21 May 31, 2021	May '20 May 31, 2020	May '19 May 31, 2019
Market Capitalization	0	9	27	38	-
Market Cap Growth	-99.99%	-67.32%	-27.84%	-	-
Enterprise Value	-	9	25	33	-
Last Close Price	0.00	0.06	0.19	0.28	-
PB Ratio	0.00	38.92	8.39	1.97	-
P/TBV Ratio	-	-	8.38	8.80	-
Quick Ratio	0.27	0.32	4.66	2.41	4.20
Current Ratio	0.30	0.38	4.84	3.19	14.87
Return on Equity (ROE)	-252.75%	-222.13%	-164.79%	-114.20%	-
Return on Assets (ROA)	-34.99%	-35.83%	-18.44%	-31.42%	-
Return on Capital Employed (ROCE)	-74.10%	-76.60%	-122.50%	-42.30%	-34.70%
Earnings Yield	-1961653.67%	-41.53%	-76.22%	-46.30%	-
FCF Yield	-	-15.53%	-12.86%	-19.90%	-
Buyback Yield / Dilution	-6.87%	-6.76%	-49.21%	-142.09%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.